Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
4-(4-dimethylaminophenylazo)benzyl-Glu-His-Val-Lys-Leu-Val-Glu-5-(2-aminoethylamino)-1-naphthalenesulfonic acid + H2O
4-(4-dimethylaminophenylazo)benzyl-Glu-His-Val-Lys + Leu-Val-Glu-5-(2-aminoethylamino)-1-naphthalenesulfonic acid
Sapp2p preferentially cleaves the Lys-Leu bond
-
-
?
4-(4-dimethylaminophenylazo)benzyl-Pro-Lys-Val-Glu-Leu-Thr-Gly-Glu-5-(2-aminoethylamino)-1-naphthalenesulfonic acid + H2O
4-(4-dimethylaminophenylazo)benzyl-Pro-Lys-Val-Glu + Leu-Thr-Gly-Glu-5-(2-aminoethylamino)-1-naphthalenesulfonic acid
the substrate is hydrolyzed preferentially at the Glu-Leu bond, however, when reaction times are prolonged, additional cleavage occurs at the Lys-Val position
-
-
?
dabcyl-Glu-His-Val-Lys-Leu-Val-Glu-EDANS
dabcyl-Glu-His-Val-Lys-COOH + Leu-Val-Glu-EDANS
-
-
-
?
dabcyl-Pro-Lys-Val-Glu-Leu-Thr-Gly-Glu-EDANS
dabcyl-Pro-Lys-Val-Glu-COOH + Leu-Thr-Gly-Glu-EDANS
-
-
-
?
PMVELAGE + H2O
PMVE + L-Leu + AGE
cleavage of Sapp2p, 81% conversion
-
-
?
PMVELQGE + H2O
PMVE + L-Leu + QGE
cleavage of Sapp2p, 18% conversion
-
-
?
PMVELTGE + 2 H2O
PMVE + L-Leu + TGE
cleavage of Sapp2p, 35% conversion
-
-
?
PMVELWGE + H2O
PMVE + L-Leu + WGE
cleavage of Sapp2p, 40% conversion
-
-
?
PMVMLWGE + H2O
PMVML + WGE
13% conversion
-
-
?
4-(4-dimethylaminophenylazo)benzyl-Glu-His-Val-Lys-Leu-Val-Glu-5-(2-aminoethylamino)-1-naphthalenesulfonic acid + H2O
4-(4-dimethylaminophenylazo)benzyl-Glu-His-Val-Lys-Leu + Val-Glu-5-(2-aminoethylamino)-1-naphthalenesulfonic acid
Sapp1p preferentially cleaves the Leu-Val bond
-
-
?
4-(4-dimethylaminophenylazo)benzyl-Pro-Lys-Val-Glu-Leu-Thr-Gly-Glu-5-(2-aminoethylamino)-1-naphthalenesulfonic acid + H2O
4-(4-dimethylaminophenylazo)benzyl-Pro-Lys-Val-Glu + Leu-Thr-Gly-Glu-5-(2-aminoethylamino)-1-naphthalenesulfonic acid
the substrate is hydrolyzed preferentially at the Glu-Leu bond, however, when reaction times are prolonged, additional cleavage occurs at the Lys-Val position
-
-
?
Ala-Thr-His-Gln-Val-Tyr-4-nitrophenylalanine-Val-Arg-Lys-Ala + H2O
Ala-Thr-His-Gln-Val-Tyr + 4-nitrophenylalanine-Val-Arg-Lys-Ala
-
-
-
-
?
Bovine serum albumin + H2O
?
-
-
-
-
?
complement component 3b + H2O
?
substrate for isoforms Sapp1p and Sapp2p
-
-
?
complement component 4b + H2O
?
substrate for isoforms Sapp1p and Sapp2p
-
-
?
Dabcyl-EHVKLVE-EDANS + H2O
?
-
-
-
-
?
dabcyl-Glu-His-Val-Lys-Leu-Val-Glu-EDANS + H2O
dabcyl-Glu-His-Val-Lys-Leu + Val-Glu-EDANS
-
-
-
-
?
ELSKRSSPS + H2O
ELSK + L-Arg + SSPS
98% conversion
-
-
?
factor H + H2O
?
substrate for isoforms Sapp1p and Sapp2p
-
-
?
factor H-related protein 5 + H2O
?
substrate for isoform Sapp2p
-
-
?
LPVNATSE + H2O
LPVN + ATSE
28% conversion
-
-
?
LTEKRDSIS + H2O
LTEKR + L-Asp + Ser-Ile-Ser
100% conversion
-
-
?
Lys-Pro-Ala-Glu-Phe-4-nitrophenylalanine-Ala-Leu + H2O
Lys-Pro-Ala-Glu-Phe + 4-nitrophenylalanine-Ala-Leu
-
-
-
-
?
Lys-Pro-Leu-Glu-Met-4-nitrophenylalanine-Ala-Leu + H2O
Lys-Pro-Leu-Glu-Met + 4-nitrophenylalanine-Ala-Leu
-
-
-
-
?
PMVELAGE + H2O
PMVEL + AGE
cleavage of Sapp1p, 100% conversion
-
-
?
PMVELGGE + H2O
PMVEL + GGE
100% conversion
-
-
?
PMVELHGE + H2O
PMVEL + HGE
100% conversion
-
-
?
PMVELPGE + H2O
PMVEL + PGE
100% conversion
-
-
?
PMVELQGE + H2O
PMVEL + QGE
cleavage of Sapp1p, 100% conversion
-
-
?
PMVELTGE + H2O
PMVEL + TGE
cleavage of Sapp1p, 100% conversion
-
-
?
PMVELWGE + H2O
PMVEL + WGE
cleavage of Sapp1p, 76% conversion
-
-
?
PMVEMWGE + H2O
PMVEM + WGE
100% conversion
-
-
?
PMVMLWGE + H2O
PMVML + WGE
98% conversion
-
-
?
additional information
?
-
additional information
?
-
sapp2p fails to cleave Lys-Pro-Ala-Glu-Phe-Phe(p-NO2)-Ala-Leu
-
-
?
additional information
?
-
-
sapp2p fails to cleave Lys-Pro-Ala-Glu-Phe-Phe(p-NO2)-Ala-Leu
-
-
?
additional information
?
-
isoform Sapp2p has a more restricted substrate specificity and significantly lower catalytic activity than isoform Sapp1p
-
-
?
additional information
?
-
isoform Sapp2p has a more restricted substrate specificity and significantly lower catalytic activity than isoform Sapp1p
-
-
?
additional information
?
-
-
isoform Sapp2p has a more restricted substrate specificity and significantly lower catalytic activity than isoform Sapp1p
-
-
?
additional information
?
-
no hydrolysis of PMVELPGE, PMVELHGE, PMVELGGE, PMVEMWGE, LPVNATSE, LTEKRDSIS, and ELSKRSSPS
-
-
?
additional information
?
-
no hydrolysis of PMVELPGE, PMVELHGE, PMVELGGE, PMVEMWGE, LPVNATSE, LTEKRDSIS, and ELSKRSSPS
-
-
?
additional information
?
-
-
no hydrolysis of PMVELPGE, PMVELHGE, PMVELGGE, PMVEMWGE, LPVNATSE, LTEKRDSIS, and ELSKRSSPS
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
benzyloxycarbonyl-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-OMe
-
benzyloxycarbonyl-L-Val-L-Val-((3R,4R)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-OMe
-
benzyloxycarbonyl-L-Val-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-( (3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-OMe
-
benzyloxycarbonyl-L-Val-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-((3R,4R)-4-amino-3-hydroxy-5-phenylpentanoic acid)-OMe
-
benzyloxycarbonyl-L-Val-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-NH2
-
benzyloxycarbonyl-L-Val-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-OH
-
benzyloxycarbonyl-L-Val-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-OMe
-
benzyloxycarbonyl-L-Val-L-Val-statine-L-Ala-statine-OH
-
(2R,3S)-phenylnorstatine
the 2R hydroxyl compound is 100- to 1000fold more potent than the 2S hydroxyl derivative
(2S,3S)-phenylnorstatine
the 2R hydroxyl compound is 100- to 1000fold more potent than the 2S hydroxyl derivative
benzyloxycarbonyl-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-OMe
-
benzyloxycarbonyl-L-Val-L-Val-((3R,4R)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-OMe
-
benzyloxycarbonyl-L-Val-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-( (3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-OMe
-
benzyloxycarbonyl-L-Val-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-((3R,4R)-4-amino-3-hydroxy-5-phenylpentanoic acid)-OMe
-
benzyloxycarbonyl-L-Val-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-NH2
-
benzyloxycarbonyl-L-Val-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-OH
-
benzyloxycarbonyl-L-Val-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-OMe
-
benzyloxycarbonyl-L-Val-L-Val-statine-L-Ala-statine-OH
-
isovaleryl-Val-Val-statyl-Ala-statyl-OH
-
-
mycogenic silver nanoparticles
-
after 24 h of incubation, significant reduction (74%) in metabolic activity is observed with 100ppm mycogenic silver nanoparticles
-
tert-butoxycarbonyl-Val-Val-(3R,4R)-4-amino-3-hydroxy-5-phenylpentanoyl-Ala-phenylstatyl-O-methyl ester
-
-
tert-butoxycarbonyl-Val-Val-phenylstatyl-Ala-(3R,4R)-4-amino-3-hydroxy-5-phenylpentanoyl-OH
-
-
tert-butoxycarbonyl-Val-Val-phenylstatyl-Ala-O-methyl ester
-
-
tert-butoxycarbonyl-Val-Val-phenylstatyl-Ala-phenylstatyl-NH2
-
-
tert-butoxycarbonyl-Val-Val-phenylstatyl-Ala-phenylstatyl-O-methyl ester
-
-
tert-butoxycarbonyl-Val-Val-phenylstatyl-Ala-phenylstatyl-OH
-
-
pepstatin A
-
-
pepstatin A
-
potent inhibitor
additional information
not inhibited by indinavir and nelfinavir
-
additional information
not inhibited by indinavir and nelfinavir
-
additional information
-
not inhibited by indinavir and nelfinavir
-
additional information
not inhibited by indinavir and nelfinavir
-
additional information
not inhibited by indinavir and nelfinavir
-
additional information
-
not inhibited by indinavir and nelfinavir
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.0000143
benzyloxycarbonyl-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-OMe
isoform Sapp2p, in 150 mM sodium citrate buffer, pH 3.75, at 37°C
0.002782
benzyloxycarbonyl-L-Val-L-Val-((3R,4R)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-OMe
isoform Sapp2p, in 150 mM sodium citrate buffer, pH 3.75, at 37°C
0.0000002
benzyloxycarbonyl-L-Val-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-( (3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-OMe
isoform Sapp2p, in 150 mM sodium citrate buffer, pH 3.75, at 37°C
0.0000001
benzyloxycarbonyl-L-Val-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-((3R,4R)-4-amino-3-hydroxy-5-phenylpentanoic acid)-OMe
isoform Sapp2p, in 150 mM sodium citrate buffer, pH 3.75, at 37°C
0.0000001
benzyloxycarbonyl-L-Val-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-NH2
isoform Sapp2p, in 150 mM sodium citrate buffer, pH 3.75, at 37°C
0.0000018
benzyloxycarbonyl-L-Val-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-OH
isoform Sapp2p, in 150 mM sodium citrate buffer, pH 3.75, at 37°C
0.0000072
benzyloxycarbonyl-L-Val-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-OMe
isoform Sapp2p, in 150 mM sodium citrate buffer, pH 3.75, at 37°C
0.00000003
benzyloxycarbonyl-L-Val-L-Val-statine-L-Ala-statine-OH
isoform Sapp2p, in 150 mM sodium citrate buffer, pH 3.75, at 37°C
0.0000004
pepstatin A
isoform Sapp2p, in 150 mM sodium citrate buffer, pH 3.75, at 37°C
0.0003
ritonavir
isoform Sapp2p, in 150 mM sodium citrate buffer, pH 3.75, at 37°C
0.32
saquinavir
isoform Sapp2p, in 150 mM sodium citrate buffer, pH 3.75, at 37°C
0.000044
benzyloxycarbonyl-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-OMe
isoform Sapp1p, in 150 mM sodium citrate buffer, pH 3.75, at 37°C
0.000174
benzyloxycarbonyl-L-Val-L-Val-((3R,4R)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-OMe
isoform Sapp1p, in 150 mM sodium citrate buffer, pH 3.75, at 37°C
0.0000003
benzyloxycarbonyl-L-Val-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-( (3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-OMe
isoform Sapp1p, in 150 mM sodium citrate buffer, pH 3.75, at 37°C
0.0000004
benzyloxycarbonyl-L-Val-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-((3R,4R)-4-amino-3-hydroxy-5-phenylpentanoic acid)-OMe
isoform Sapp1p, in 150 mM sodium citrate buffer, pH 3.75, at 37°C
0.0000001
benzyloxycarbonyl-L-Val-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-NH2
isoform Sapp1p, in 150 mM sodium citrate buffer, pH 3.75, at 37°C
0.0000066
benzyloxycarbonyl-L-Val-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-OH
isoform Sapp1p, in 150 mM sodium citrate buffer, pH 3.75, at 37°C
0.0000146
benzyloxycarbonyl-L-Val-L-Val-((3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid)-L-Ala-OMe
isoform Sapp1p, in 150 mM sodium citrate buffer, pH 3.75, at 37°C
0.0000003
benzyloxycarbonyl-L-Val-L-Val-statine-L-Ala-statine-OH
isoform Sapp1p, in 150 mM sodium citrate buffer, pH 3.75, at 37°C
0.0000003
isovaleryl-Val-Val-statyl-Ala-statyl-OH
-
-
0.0000003
pepstatin A
isoform Sapp1p, in 150 mM sodium citrate buffer, pH 3.75, at 37°C
0.0019
ritonavir
isoform Sapp1p, in 150 mM sodium citrate buffer, pH 3.75, at 37°C
0.0169
saquinavir
isoform Sapp1p, in 150 mM sodium citrate buffer, pH 3.75, at 37°C
0.005301
tert-butoxycarbonyl-Val-Val-(3R,4R)-4-amino-3-hydroxy-5-phenylpentanoyl-Ala-phenylstatyl-O-methyl ester
-
-
0.0000009
tert-butoxycarbonyl-Val-Val-phenylstatyl-Ala-(3R,4R)-4-amino-3-hydroxy-5-phenylpentanoyl-OH
-
-
0.0000065
tert-butoxycarbonyl-Val-Val-phenylstatyl-Ala-O-methyl ester
-
-
0.00000254
tert-butoxycarbonyl-Val-Val-phenylstatyl-Ala-phenylstatyl-NH2
-
-
0.0000004
tert-butoxycarbonyl-Val-Val-phenylstatyl-Ala-phenylstatyl-O-methyl ester
-
-
0.0000066
tert-butoxycarbonyl-Val-Val-phenylstatyl-Ala-phenylstatyl-OH
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Dostal, J.; Dlouha, H.; Malon, P.; Pichova, I.; Hruskova-Heidingsfeldova, O.
The precursor of secreted aspartic proteinase Sapp1p from Candida parapsilosis can be activated both autocatalytically and by a membrane-bound processing proteinase
Biol. Chem.
386
791-799
2005
Candida parapsilosis
brenda
Majer, F.; Pavlickova, L.; Majer, P.; Hradilek, M.; Dolejsi, E.; Hruskova-Heidingsfeldova, O.; Pichova, I.
Structure-based specificity mapping of secreted aspartic proteases of Candida parapsilosis, Candida albicans, and Candida tropicalis using peptidomimetic inhibitors and homology modeling
Biol. Chem.
387
1247-1254
2006
Candida albicans (P0DJ06), Candida albicans, Candida parapsilosis (P32951), Candida parapsilosis, Candida tropicalis (Q00663), Candida tropicalis
brenda
Merkerova, M.; Dostal, J.; Hradilek, M.; Pichova, I.; Hruskova-Heidingsfeldova, O.
Cloning and characterization of Sapp2p, the second aspartic proteinase isoenzyme from Candida parapsilosis
FEMS Yeast Res.
6
1018-1026
2006
Candida parapsilosis (P32950), Candida parapsilosis, Candida parapsilosis CP386/IDE98 (P32950)
brenda
Hruskova-Heidingsfeldova, O.; Dostal, J.; Majer, F.; Havlikova, J.; Hradilek, M.; Pichova, I.
Two aspartic proteinases secreted by the pathogenic yeast Candida parapsilosis differ in expression pattern and catalytic properties
Biol. Chem.
390
259-268
2009
Candida parapsilosis (P32950), Candida parapsilosis (P32951), Candida parapsilosis, Candida parapsilosis P-69 (P32950), Candida parapsilosis P-69 (P32951)
brenda
Dostal, J.; Brynda, J.; Hruskova-Heidingsfeldova, O.; Sieglova, I.; Pichova, I.; Rezacova, P.
The crystal structure of the secreted aspartic protease 1 from Candida parapsilosis in complex with pepstatin A
J. Struct. Biol.
167
145-152
2009
Candida parapsilosis, Candida parapsilosis P-69
brenda
Parra-Ortega, B.; Cruz-Torres, H.; Villa-Tanaca, L.; Hernandez-Rodriguez, C.
Phylogeny and evolution of the aspartyl protease family from clinically relevant Candida species
Mem. Inst. Oswaldo Cruz
104
505-512
2009
Candida albicans, Pichia kudriavzevii, [Candida] glabrata, Meyerozyma guilliermondii, Kluyveromyces marxianus, Candida parapsilosis, Candida tropicalis, Clavispora lusitaniae, Candida dubliniensis
brenda
Costa, C.R.; Jesuino, R.S.; de Aquino Lemos, J.; de Fatima Lisboa Fernandes, O.; Hasimoto e Souza, L.K.; Passos, X.S.; do Rosario Rodrigues Silva, M.
Effects of antifungal agents in Sap activity of Candida albicans isolates
Mycopathologia
169
91-98
2010
Candida albicans, Candida parapsilosis
brenda
Vinterova, Z.; Sanda, M.; Dostal, J.; Hruskova-Heidingsfeldova, O.; Pichova, I.
Evidence for the presence of proteolytically active secreted aspartic proteinase 1 of Candida parapsilosis in the cell wall
Protein Sci.
20
2004-2012
2011
Candida parapsilosis
brenda
Dostal, J.; Pecina, A.; Hruskova-Heidingsfeldova, O.; Mareckova, L.; Pichova, I.; Rezacova, P.; Lepsik, M.; Brynda, J.
Atomic resolution crystal structure of Sapp2p, a secreted aspartic protease from Candida parapsilosis
Acta Crystallogr. Sect. D
71
2494-2504
2015
Candida parapsilosis (G8B6Y8), Candida parapsilosis, Candida parapsilosis CDC-317 (G8B6Y8)
brenda
Hamid, S.; Zainab, S.; Faryal, R.; Ali, N.; Sharafat, I.
Inhibition of secreted aspartyl proteinase activity in biofilms of Candida species by mycogenic silver nanoparticles
Artif. Cells Nanomed. Biotechnol.
46
551-557
2018
Candida albicans, Pichia kudriavzevii, [Candida] glabrata, Candida parapsilosis, Candida tropicalis
brenda
Singh, D.; Nemeth, T.; Papp, A.; Toth, R.; Lukacsi, S.; Heidingsfeld, O.; Dostal, J.; Vagvoelgyi, C.; Bajtay, Z.; Jozsi, M.; Gacser, A.
Functional characterization of secreted aspartyl proteases in Candida parapsilosis
mSphere
4
e00484-19
2019
Candida parapsilosis (P32951), Candida parapsilosis
brenda